Viral Hepatitis
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2007; 13(6): 837-844
Published online Feb 14, 2007. doi: 10.3748/wjg.v13.i6.837
Table 5 Diagnostic performance of serum M30-antigen and M65-antigen levels for the diagnosis of definitive NASH
PatientcategorySerumbiomarkerCut-off value1(IU/L)Sensitivity(95% CI)Specificity(95% CI)Positive predictivevalue (%)Negative predictivevalue (%)Negativelikelihood ratioArea under theROC curve (95% CI)
Borderline NASHM30-antigen121.660 (44.3-74.3)95.8 (78.8-99.3)96.4056.100.420.783 (0.668-0.783)
M65-antigen241.3468.9 (53.3-81.8)83.3 (62.6-95.2)88.6058.800.370.809 (0.697-0.894)
Simple steatosisM30-antigen109.6462.2 (46.5-76.2)100 (66.2-100.0)100.0034.600.380.83 (0.703-0.918)
M65-antigen186.7793.3 (81.7-98.5)66.7 (30.1-92.1)93.3066.700.100.807 (0.677-0.902)
Normal tissueM30-antigen96.564.4 (48.8-78.1)100 (48.0-100.0)100.0023.800.360.724 (0.508-0.841)
M65-antigen227.1873.3 (58.1-85.4)80 (28.8-96.7)97.1025.000.330.809 (0.673-0.906)
Healthy controlsM30-antigen82.5275.6 (60.5-87.1)85.7 (72.7-94.0)82.9079.200.290.881 (0.798-0.938)
M65-antigen189.6491.4 (77.6-98.6)68.1 (36.1-94.2)92.0068.200.180.94 (0.839-0.980)
No-NASHM30-antigen121.660 (44.3-74.3)97.4 (86.1-99.6)96.4067.300.410.787 (0.683-0.869)
M65-antigen243.8268.9 (53.3-81.8)81.6 (65.7-92.2)81.6068.900.380.809 (0.708-0.887)